|Mr. John L. Erb||Chairman, CEO & Pres||595.47k||N/A||1949|
|Ms. Claudia Napal Drayton||Chief Financial Officer||373.65k||N/A||1968|
|Mr. Vitaliy Epshteyn||Sr. VP of Operations & Engineering||N/A||N/A||1978|
|Mr. David Lerner||Sr. VP of Corp. Devel. & Technology||N/A||N/A||N/A|
|Mr. Thomas P. Lynch||VP, Gen. Counsel, Chief Compliance Officer & Sec.||N/A||N/A||1967|
CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
CHF Solutions, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.